HOME >> BIOLOGY >> NEWS
Prevalence of ICU nurses has strong link to patient outcomes

Patients undergoing high-risk surgeries are more likely to have post-operative complications, including difficulty breathing, if their hospital's intensive care unit (ICU) isn't sufficiently staffed by nurses, according to a Johns Hopkins study of Maryland hospitals.

Results of the study, published in the October issue of Effective Clinical Practice, a journal of the American College of Physicians, indicate that while the optimal nurse-to-patient ratio remains to be determined, intensive care units having ratios of one nurse for every three or four patients, rather than one or two, have significantly higher rates of post-surgical complications.

Overall, 47 percent of patients treated in hospitals with fewer ICU nurses and 34 percent treated in hospitals with more ICU nurses had at least one complication. Patients treated in hospitals with fewer ICU nurses were more likely to have medical complications (43 percent vs. 28 percent) or respiratory failure (21 percent vs. 13 percent), or need a breathing tube re-inserted (21 percent vs. 13 percent). Nurse staffing did not affect the risk for surgical complications.

"Nurses who care for three or more patients may have less time to devote to patient care especially preventive measures, such as post-operative pulmonary care," says Peter J. Pronovost, M.D., Ph.D., lead author of the study and associate professor of anesthesiology and critical care medicine. "Hospital administrators who reduce the number of ICU nurses in order to cut costs may actually cost themselves more in the long run."

For the study, researchers analyzed hospital discharge data for 2,606 abdominal aortic aneurysm patients who were treated at 38 hospitals in Maryland between 1994 and 1996, looking at medical and surgical complications such as pulmonary problems, kidney failure, heart complications, bloodstream infection and post-operative bleeding. People with abdominal aneurysm -- a dangerous ballooning of a ma
'"/>

Contact: Karen Blum
kblum@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
18-Oct-2001


Page: 1 2

Related biology news :

1. Hopkins Study Shows High Prevalence Of Domestic Violence
2. Nanonurses
3. When suns too strong, plankton make clouds
4. Triple-vaccine strategy stimulates strong HIV-specific immune response in monkeys
5. Clinical judgement still counts strongly alongside genetic testing
6. Food tastes stronger when youre hungry
7. Aspirin may not be strong enough to prevent clots in some heart patients
8. Experimental hantavirus vaccine elicits strong antibody response in primates
9. Ki-67 biomarker a strong predictor of outcome for prostate cancer patients
10. Smallest whirlpools can pack stunningly strong force
11. Expressing strong concern at human cloning reports, AAAS cautions against overreaction

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Prevalence ICU nurses has strong link patient outcomes

(Date:5/24/2013)... years, microRNAs (miRNAs) and other non-coding RNAs are ... specific proteins. In recent years they have emerged ... to establish tissue origin for cancers of unknown ... screen for disease, but clinically tractable, diagnostic methods ... not currently available. In this issue of the ...
(Date:5/23/2013)... , Automated conserved noncoding sequence (CNS) discovery ... grasses , Within the genome of each species, ... little change in position and sequence over millions of ... of these evolutionarily stable sequences, so-called conserved noncoding sequences ... genes or the condensation of chromosomes, but the function ...
(Date:5/23/2013)... Rollins School of Public Health at Emory University, ... Technology, have received a $4 million grant over ... Emory University (Health and Exposome Research Center: Understanding ... center grant awarded in the United States. ... National Institute of Environmental Health Sciences (NIEHS) of ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
(Date:5/23/2013)... May 23, 2013 PuraMed BioScience ® ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... on the company based on low market capitalization ... Non-Prescription, All Natural Product to Treat Migraine Headaches ... #1 Prescription Competitor , Currently Available Nationwide ...
(Date:5/23/2013)... Calif. , May 23, 2013  Saddleback Memorial ... recently became the first hospital on the West ... technology. This new surgical option provides women with a ... Marc Winter , M.D., a ... and surgeon and medical director of minimally invasive surgery ...
(Date:5/23/2013)... Md. , May 23, 2013 Northwest ... biotechnology company developing DCVax ® personalized immune therapies ... use its exhibit at this year,s American Society Of ... to highlight its leadership role in immune therapy.  ... The ASCO annual meeting is the pre-eminent conference focused ...
(Date:5/23/2013)... May 23, 2013 Pusan National University ... private biotherapeutics and contract research company focused on ... cancer, announced today a publication reporting the induction ... the oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; ... published in the May 15 th , 2013 ...
Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3
Cached News: